
A São Paulo state court has upheld a decision requiring a health insurer to apply annual rate adjustments for individual and family plans to a corporate policy covering just four people. The ruling came from the 2nd Civil Recursive Chamber of the TJ/SP, dismissing the insurer’s claim that the contract qualified as a legitimate collective plan.
The dispute originated when a company contested the insurer’s 2023, 2024, and 2025 rate increases, 23.79%, 20.96%, and 15.11%, on a plan that initially covered three policyholders and one dependent. The initial lawsuit argued these hikes violated the National Health Supplement Agency’s (ANS) annual limits for individual and family plans.
Lower courts had already sided with the plaintiffs, labeling the arrangement a “false collective” plan. The ANS imposes stricter annual caps on individual and family policies, which are generally lower than those permitted for corporate plans. The first judge determined the contract lacked genuine collective bargaining, noting that two of the three policyholders were brothers who were also company shareholders.
The insurer’s appeal argued the contract was validly collective and that its rate calculations, based on medical-hospital cost variations (VCMH) and claim frequency, were standard for corporate plans. It also claimed the small claims court lacked the expertise to assess the dispute without actuarial analysis.
Judge Beatriz de Souza Cabezas rejected these claims in the appeals ruling. She observed that collective status cannot be determined solely by the number of beneficiaries. In this case, the group’s composition, two related shareholders and a single dependent, undermined the notion of a broad, negotiated collective agreement. The court stressed that ANS limits apply when contracts lack true collective characteristics, even if they are formally classified as such.
Although the insurer must now adhere to individual and family rate caps, the ruling does not mandate full refunds. Policyholders will recover only the overcharged portions of premiums paid since the disputed increases took effect, excluding any amounts beyond the three-year prescription limit. The exact calculations will be finalized during the enforcement stage of the judgment.
The case was managed by Cardoso Advocacia. According to Article 46 of Law 9.099/95, the appeals court’s decision is now final, as it governs small claims proceedings in Brazil.


